HRT
Overvalued by 79.1% based on the discounted cash flow analysis.
Market cap | $967.19 Million |
---|---|
Enterprise Value | $1.65 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $-0.16 |
Beta | 0.78 |
Outstanding Shares | 67,351,727 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -134.5 |
---|---|
PEG | 243.54 |
Price to Sales | 1.44 |
Price to Book Ratio | 2.39 |
Enterprise Value to Revenue | 2.29 |
Enterprise Value to EBIT | 23.52 |
Enterprise Value to Net Income | -229 |
Total Debt to Enterprise | 0.46 |
Debt to Equity | 1.68 |
No data
No data